• Journal of Microbiology and Biotechnology
• /
• 제25권12호
• /
• pp.2058-2071
• /
• 2015

A comparative study was conducted to evaluate precision and accuracy in controlling the temperature dependence of encapsulated microbial time-temperature integrators (TTIs) developed using two different emulsification techniques. Weissela cibaria CIFP 009 cells, immobilized within 2% Na-alginate gel microbeads using homogenization (5,000, 7,000, and 10,000 rpm) and Shirasu porous glass (SPG) membrane technologies (10 μm), were applied to microbial TTIs. The prepared micobeads were characterized with respect to their size, size distribution, shape and morphology, entrapment efficiency, and bead production yield. Additionally, fermentation process parameters including growth rate were investigated. The TTI responses (changes in pH and titratable acidity (TA)) were evaluated as a function of temperature (20℃, 25℃, and 30℃). In comparison with conventional methods, SPG membrane technology was able not only to produce highly uniform, small-sized beads with the narrowest size distribution, but also the bead production yield was found to be nearly 3.0 to 4.5 times higher. However, among the TTIs produced using the homogenization technique, poor linearity (R²) in terms of TA was observed for the 5,000 and 7,000 rpm treatments. Consequently, microbeads produced by the SPG membrane and by homogenization at 10,000 rpm were selected for adjusting the temperature dependence. The E_a values of TTIs containing 0.5, 1.0, and 1.5 g microbeads, prepared by SPG membrane and conventional methods, were estimated to be 86.0, 83.5, and 76.6 kJ/mol, and 85.5, 73.5, and 62.2 kJ/mol, respectively. Therefore, microbial TTIs developed using SPG membrane technology are much more efficient in controlling temperature dependence.

• 상하수도학회지
• /
• 제14권1호
• /
• pp.37-44
• /
• 2000

Laboratory experiments were conducted to investigate the performances of anaerobic filters packed with ceramic tube and pall-ring media treating a dairy waste. The media packing volume was 65% of effective volume of anaerobic filter. Organics removals of anaerobic filters were maintained above 80% even at an organics loading rate of $10kgCOD/m^3/d$, and this was comparable to aerobic treatment of organic wastes. Organics removals of the ceramic tube anaerobic filters were always lower than those of the pall-ring anaerobic filters due to intrinsic physical property of ceramic tube, especially lower void space which caused to clogging and entrapment of biogas, substrate transfer limitation, and irregular evolution of biogas leading to loss of solids and biomass. This was clearly observed in higher concentration of TSS in the effluent from the ceramic tube anaerobic filter despite of higher retention capacity of TSS compared with pall-ring media. Vertical distribution of organics and solids in the filters showed above 90% of organics and solids in influent were removed below 20% of reactor height, and 50% of remaining organics and solids were removed though media packing zone. Effluent quality from the anaerobic filter was heavily depended on media itself as well as suspended biomass formed below media. It is therefore concluded that the type of media played an important role in biomass accumulation arid gas-liquid-solid separation efficiency. Type of media did not affect the start-up behaviors of the anaerobic filter, and supernatant from anaerobic digested sludge showed a good performance as a seeding materials.

• Journal of Pharmaceutical Investigation
• /
• 제38권1호
• /
• pp.63-72
• /
• 2008

Meloxicam-loaded microspheres were prepared with poly(D,L-lactic acid)(PLA) by a solvent-emulsion evaporation method. The morphology, particle size, drug loading capacity, drug entrapment efficiency (EE) and release patterns of drug were investigated in vitro. Various batches of micro spheres with different size and drug content were obtained by changing the ratio of meloxicam to $PLA^{\circ}{\AE}s$ with different molecular weight, PLA concentration in the dispersed phase and stirring rate. Meloxicam crystals on microsphere surface, which were released rapidly and could act as a loading dose, were observed with increasing drug content. The release rate was increased with increase in drug contents and decrease in the molecular weight of PLA. Microspheres prepared with smaller molecular weight produced faster drug release rate. The release rate of meloxicam for long-acting injectable delivery system in vitro, which would aid in predicting in vivo release profile, could be controlled by properly optimizing various factors affecting characteristics of microspheres. Blood concentration-time profile of meloxicam after intramuscular injection of meloxicam-loaded microspheres in rabbits showed possibility of long term application of this system in clinical settings.

• International Journal of Naval Architecture and Ocean Engineering
• /
• 제5권2호
• /
• pp.227-245
• /
• 2013

Reliable strength assessment of the Liquefied Natural Gas (LNG) cargo containment system under the sloshing impact load is very difficult task due to the complexity of the physics involved in, both in terms of the hydrodynamics and structural mechanics. Out of all those complexities, the proper selection of the design sloshing load which is applied to the structural model of the LNG cargo containment system, is one of the most challenging one due to its inherent randomness as well as the statistical analysis which is tightly linked to the design sloshing load selection. In this study, the response based strength assessment procedure of LNG cargo containment system has been developed and proposed as an alternative design methodology. Sloshing pressure time history, measured from the model test, is decomposed into wavelet basis function targeting the minimization of the number of the basis function together with the maximization of the numerical efficiency. Then the response of the structure is obtained using the finite element method under each wavelet basis function of different scale. Finally, the response of the structure under entire sloshing impact time history is rapidly calculated by synthesizing the structural response under wavelet basis function. Through this analysis, more realistic response of the system under sloshing impact pressure can be obtained without missing the details of pressure time history such as rising pattern, oscillation due to air entrapment and decay pattern and so on. The strength assessment of the cargo containment system is then performed based on the statistical analysis of the stress peaks selected out of the obtained stress time history.

• Journal of Pharmaceutical Investigation
• /
• 제34권6호
• /
• pp.483-489
• /
• 2004

Fexofenadine HCl is non-sedating histamine H1 receptor antagonist that can be used for the treatment of seasonal allergic rhinitis. The objective of this study was to investigate whether the carriers of deformable liposomes can enhance the transepithelial permeability of fexofenadine HCl across the in vitro ALI human nasal monolayer model. Characterization of this model was achieved by bioelectric measurements and morphological studies. The passage 2 and 3 of cell monolayers exhibited the TEER value of $2852\;{\pm}\;482\;ohm\;{\times}\;cm^2$ on 11 days of seeding and maintained high TEER value for 5 days. The deformable liposome of fexofenadine HCl was prepared with phosphatidylcholine (PC) and cholic acid using extruder method. The mean particle size was about 200 nm and the maximum entrapment efficiency of 33.0% was obtained in the formulation of 1% PC and $100\;{\mu}g/ml$ fexofenadine HCl. The toxicity of the deformable liposome to human nasal monolayers was evaluated by MTT assay and TEER value change. MTT assay showed that it has no toxic effect on the nasal epithelial cells in 2-hour incubation when the PC concentration was below 1%. However, deformable liposome could not enhance the transepithelial permeability $(P_{app})$ and cellular uptake of fexofenadine HCl. In conclusion, the in vitro model could be used in nasal drug transport studies and evaluation of transepithelial permeability of formulations.

• The Korean Journal of Physiology and Pharmacology
• /
• 제28권3호
• /
• pp.275-284
• /
• 2024

Worldwide, cardiovascular disease is the main cause of death, which accordingly increased by hyperlipidemia. Hyperlipidemia therapy can include lifestyle changes and medications to control cholesterol levels. Statins are the medications of the first choice for dealing with lipid abnormalities. Rosuvastatin founds to control high lipid levels by hindering liver production of cholesterol and to achieve the targeted levels of low-density lipoprotein cholesterol, another lipid lowering agents named ezetimibe may be used as an added therapy. Both rosuvastatin and ezetimibe have low bioavailability which will stand as barrier to decrease cholesterol levels, because of such depictions, formulations of this combined therapy in nanotechnology will be of a great assistance. Our study demonstrated preparations of nanoparticles of this combined therapy, showing their physical characterizations, and examined their behavior in laboratory conditions and vivo habitation. The mean particle size was uniform, polydispersity index and zeta potential of formulations were found to be in the ranges of (0.181-0.72) and (-13.4 to -6.24), respectively. Acceptable limits of entrapment efficiency were affirmed with appearance of spherical and uniform nanoparticles. In vitro testing showed a sustained release of drug exceeded 90% over 24 h. In vivo study revealed an enhanced dissolution and bioavailability from loaded nanoparticles, which was evidenced by calculated pharmacokinetic parameters using triton for hyperlipidemia induction. Stability studies were performed and assured that the formulations are kept the same up to one month. Therefore, nano formulations is a suitable transporter for combined therapy of rosuvastatin and ezetimibe with improvement in their dissolution and bioavailability.

• Journal of Ginseng Research
• /
• 제48권4호
• /
• pp.417-424
• /
• 2024

Background: This research main objective was to evaluate a proliposomes (PLs) formulation for the enhancement of oral bioavailability of ginsenosides, using ginsenoside Rg3 (Rg3) as a marker. Methods: A novel PLs formulation was prepared using a modified evaporation-on-matrix method. Soy phosphatidylcholine, Rg3-enriched extract, poloxamer 188 (Lutrol® F 68) and sorbitol were mixed and dissolved using a aqueous ethanolic solution, followed by the removal of ethanol and lyophilization. The characterization of Rg3-PLs formulations was performed by powder X-ray diffractometry (PXRD), transmission electron microscopy (TEM) and in vitro release. The enhancement of oral bioavailability was investigated and analyzed by noncompartmental parameters after oral administration of the formulations. Results: PXRD of Rg3-PLs indicated that Rg3 was transformed from crystalline into its amorphous form during the preparation process. The Rg3-encapsulated liposomes with vesicular-shaped morphology were generated after the reconstitution by gentle hand-shaking in water; they had a mean diameter of approximately 350 nm, a negative zeta potential (- 28.6 mV) and a high entrapment efficiency (97.3%). The results of the in vitro release study exhibited that significantly more amount of Rg3 was released from the PLs formulation in comparison with that from the suspension of Rg3-enriched extract (control group). The pharmacokinetic parameters after oral administration of PLs formulation in rats showed an approximately 11.8-fold increase in the bioavailability of Rg3, compared to that of the control group. Conclusion: The developed PLs formulation could be a favorable delivery system to improve the oral bioavailability of ginsenosides, including Rg3.

• 공업화학
• /
• 제26권2호
• /
• pp.165-172
• /
• 2015

쿼세틴과 쿼세틴의 배당체인 루틴은 천연 항산화제로 잘 알려진 플라보노이드이다. 본 연구에서는 플라보노이드(쿼세틴과 루틴)를 담지한 양이온 리포좀을 제조하여 세포 및 피부 투과성과 자외선(UVA)에 대한 HaCaT 세포 보호 효과를 평가하였다. 빈 양이온 리포좀의 입자 크기는 100~130 nm이며, 입자 표면 전위는 + 33.05 mV를 나타내었다. 포집효율은 루틴을 담지한 리포좀과 양이온 리포좀이 쿼세틴을 담지한 경우보다 높았다. 세포 내 이입율 비교결과, 양이온 리포좀이 일반 리포좀에 비해 약 5배 정도 높음을 확인했다. In vitro 상에서, 쿼세틴과 루틴이 용해된 PBS (phosphate-buffered saline) 수용액, 동량의 쿼세틴과 루틴을 담지한 리포좀과 양이온 리포좀의 피부투과율을 비교하였다. 양이온 리포좀에 담지하였을 경우 가장 높은 피부투과율을 보였다. 플라보노이드를 담지한 양이온 리포좀의 자외선(UVA $25J/cm^2$)에 대한 HaCaT 세포 보호 효과를 측정한 결과, 자외선만 조사한 군에 비해 플라보노이드 담지 양이온 리포좀을 처리한 군에서 높은 세포 보호 효과를 보였다. 결과적으로, 양이온 리포좀은 플라보노이드를 피부 속으로 전달하는데 있어서 매우 유용한 피부 전달 시스템임을 확인하였다. 따라서, 세포 보호 및 피부 흡수 증진 효과를 가지는 양이온 리포좀은 항노화 및 항산화 화장품 제형으로써 활용 가능성이 있음을 시사한다.

• 한국임상수의학회지
• /
• 제22권3호
• /
• pp.175-180
• /
• 2005

본 연구는 개에서 키토산 비드를 이용한 cefadroxil 방출에 영향을 주는 인자, 약물을 함유한 최적의 키토산 비드의 제조, 그리고 키토산 비드로부터 약물의 방출을 평가하는 것이다. 키토산 비드는 tripolyphosphate (TPP)와 이온결합으로 생성되며 비드의 크기는 1 mm 미만이었다. 비드로부터 cefadroxil 방출은 여러 인자에 영항을 받는다. TPP의 pH가 감소할수록 cefadroxil의 비드내 함유량은 증가하지만, 비드로부터 방출량은 감소한다. Cefadroxil의 방출속도은 TPP 농도가 증가할수록 감소한다. 결합시간이 길어지면, 방출량이 감소한다. Cefadroxil을 함유한 키토산 비드를 50 mg/kg 용량으로 건강한 개 4두의 피하에 이식한 결과, cefadroxil의 혈청내 농도는 1 ${\mu}g/ml$ 이상으로 7일간 유지되었다. 따라서 cefadroxil을 함유한 키토산 비드는 개의 농피증 치료에 유용한 것으로 사료되며 약물방출을 통제할 수 있는 약물수송체가 이용될 수 있다고 사료된다.

• 한국식품과학회지
• /
• 제28권3호
• /
• pp.399-404
• /
• 1996

Liposome내에 효소를 포집시켜서 식품가공공정에 응용하기 위하여 모델 효소로서 Iysozyme을 선택하여 dehydration-rehydration법으로 미세캡술화시킬 때 조제 조건이 포집효율에 미치는 영향을 검토하고 외부 환경 인자의 변화 및 유출 촉진제의 첨가가 liposome 내의 효소의 유출에 미치는 영향을 연구하였다. MLV 현탁액을 bath sonicator에서 100 kHz로 2시간 초음파 처리했을 때 1ozyme의 포집효율이 90.9%로 가장 높았다. 초기 효소 첨가량을 증가시킴으로써 단위 지방질당 포집 효소량은 거의 비례적으로 증가하였으나 포집효율은 감소하여 1osozyme 50 mg/100 mg soy lecithin일 때 68% 수준까지 급격히 감소하였으나, 그 이상의 실험농도 범위에서는 매우 완만하였다. 효소를 포집한 liposome은 $37^{\circ}C$, pH 5.9에 저장하였을때에 가장 안정하였고 산성일수록 유출속도는 현저히 증가하였으며 일정한 속도로 지속적으로 유출되었다. Tween 80 1.0%와 흔합했을 때 초기 24시간 동안에는 급격히 유출되었으나 시간이 경과할수록 완만히 유출되어 72시간 경과 후 85%까지 유출되었다. 또한 $Ca^{2+}$ ion을 25-5OmM첨가했을 때 초기 1시간동안 급격히 유출되었으나 그 이후에는 완만히 유출되었다.